A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

Trial statusRecruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age18+

SponsorOno Pharmaceutical Co., Ltd.

About this trial

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

Angioimmunoblastic T-cell lymphoma(AITL)

Peripheral T-cell lymphoma, NOS(PTCL-NOS)

Nodal peripheral T-cell lymphoma with TFH phenotype(nodal PTCL with TFH)

Follicular T-cell lymphoma(FTCL) Cutaneous T-cell lymphoma(CTCL)

Patients with severe complications.

Patients with multiple cancers.

108 Participants

are divided into 1 treatment group

Locations14

Select a site below to view it on the map.

Ono Pharmaceutical Co., Ltd.

Lead sponsor